Nuestros cursos en español

Ofrecemos un curso pregrabado con créditos aprobados por el NYSED para las personas que hablan español.

Terapia cognitivo-conductual esencial para el tratamiento de los trastornos por consumo de sustancias | 2. 5 créditos de educación continua | Gratuito

La terapia cognitivo-conductual es una de las técnicas más eficaces utilizadas para facilitar el crecimiento y el cambio del paciente. Las representaciones en video de métodos fáciles de utilizar para pacientes que consumen sustancias le ayudarán a mejorar sus habilidades. . . . Leer más

Antecedentes de los cursos de investigación de Connections Counseling PLLC disponibles en español

Hay un curso en español que se utiliza actualmente con fines de investigación. Se trata del curso Terapia cognitivo‑conductual esencial para el tratamiento de los trastornos por consumo de sustancias, que se está utilizando en uno estudio, descritos más adelante. El objetivo general de este curso clínico es que los profesionales en capacitación desarrollen confianza y motivación para utilizar la terapia cognitivo‑conductual (TCC) en sus consultas. El curso Terapia cognitivo‑conductual esencial para el tratamiento de los trastornos por consumo de sustancias 2023 se imparte de manera virtual y ha recibido buenas críticas de quienes lo han realizado. Si desea realizar este curso de forma gratuita y participar en un estudio de investigación, el único requisito es que acepte que su información anonimizada (encuestas llenadas sin incluir su nombre) pueda utilizarse para la investigación. Durante el curso “Terapia cognitivo‑conductual esencial…” se espera que realice un evaluacion que duran de 10 a 15 minutos relativas a su práctica profesional, un prueba posterior y que evalúe la información y la calidad de la capacitación. No hay ni habrá penalización por no participar. Sus respuestas serán confidenciales. Si decide no participar en este momento, puede volver a inscribirse en la capacitación más adelante.

PREGUNTAS FRECUENTES SOBRE LA INVESTIGACIÓN

About the Ethics for the Counseling Professions course

For this February. . . .2019 BPTI training information. . .


NEW! –Ethics for the Counseling Professions is a course that covers ethical values which are the basis for ethical counselor practice. Course covers social work, mental health counselor and CASAC ethical codes, covers ethical decision making in the areas of confidentiality, technological advances, immigration and addictions. Bioethics research fellow Dr. Tim Campbell walks us through cases which require ethical decision-making in all areas. Course available in February, 2019.

Ethics for the Counseling Professions is a new course from BPTI. It is being offered to LMSWs, LCSWs, LMHCs, and CASACs beginning in February, 2019. The Ethics course is being offered as part of a research study for counselors. Find out more about the trainings and specifics for your licensure and state by clicking on the links). This training  focuses on Ethical Codes for the counselors mentioned above, and demonstrates ethical decision-making practices. It specifically focuses on ethical decision making in conflicted situations. It is designed to bolster clinician confidence and motivation to use a Harms and Benefits analysis in the areas of confidentiality, technological advances, immigration and addictions.   
     The filmed commentaries on case scenarios are done by bioethics researcher Dr. Timothy Campbell. This training has been NY State-approved for LCSWs and LMSWs, and OASAS approved for re-crentialing CASACs.

Course Goals and Objectives. .  .

The Ethics for the Counseling Professions is new for 2019. Participants will gain an understanding of the ethical underpinnings of counseling codes and how to use those general value guidelines to make ethical decisions in value-conflicted situations.

Objective 1. Participants will understand the basic ethical principles which underpin the ethical codes of the social work, mental health, and CASAC counseling professions.
Objective 2. Participants will understand the ethical code for their specific licensure.
Objective 3. Participants will understand how to do a Harms and Benefits analysis in a paradigm case concerning a  value-conflicted situation –  the classic Tarasoff Decision. Objective 4. Participants will understand the updates to the ethical codes in the area of technology use. They will be exposed to a value-conflicted situation concerning technology use by a counselor, and learn how to use a harms and benefits analysis to resolve such a situation. They will learn suggestions which have been made to safeguard their own use of advanced technology in the counseling profession.
Objective 5. Participants will understand the current situation in the U.S. concerning immigration. They will be exposed to a value-conflicted situation concerning an immigration case, and learn how to use a harms and benefits analysis to resolve such a situation.
Objective 6. Participants will understand the current situation in the U.S. concerning addiction. They will be exposed to a value-conflicted situation concerning a case affected by addiction, and learn how to use a harms and benefits analysis to resolve such a situation.

Timed Course Agenda: expected to complete in 6 hours, self-paced
1.
 (1.0 hours) General ethical principles and how those principles are expressed in Counselor Codes of Conduct
 2. (.5 hours) Demonstration of a Harms and Benefits analysis using the Tarasoff Decision which poses a value conflict concerning client confidentiality, highlighting a conflict between client Autonomy and Beneficence.
 3. (1.0 hours) General outline of technological advances which have affected the counseling professions
 4. (.5 hours) Demonstration of a Harms and Benefits analysis using the Ngole case which posed a value conflict concerning the use of technology by a social work student, highlighting a conflict between student Autonomy and client Beneficence and Justice
 5. (1.0 hours) General outline of U.S. immigration issues.
 6.  (.5  hours) Demonstration of a Harms and Benefits analysis using a hypothetical immigration case which poses a value conflict for those in the counseling profession.
 7. (1.0 hours) General outline of U.S. addiction prevalence, and biopsychosocial effects of addiction on individuals.
8. (.5 hours) Demonstration of a Harms and Benefits analysis using a hypothetical case in which issues of addiction pose a value conflict for those in the counseling profession.

BPTI News 9-21 We’re fighting the Opioid epidemic

BPTI News: Fighting the Opioid Crisis

There is good news from the front of the fight against the opioid epidemic. Several news services reported the Department of Health and Human Services (DHHS) would be giving $1billion in federal grants to states to fight opioid addiction (Azar, 2018). These grants go to all states to fund addiction treatment, prevention, and recovery services. There are also grants from the Centers for Disease Control and Prevention to improve data gathering and prevention. Special funding goes to health centers in rural areas to help them provide addiction treatment.
Two important changes stand out in that funding. Medication-assisted treatment (MAT) which has been in short supply for the treatment of opioid addiction, will be expanded through the funding of  the use of telemedicine to provide MAT. MAT is any treatment for opioid addiction that includes a medication (e.g., methadone, buprenorphine, levo-alpha acetyl methadol [LAAM], naltrexone, suboxone) approved by the U.S. Food and Drug Administration (FDA) for opioid addiction detoxification or maintenance treatment.
Prescribing drugs that are used in MAT requires certification and training of physicians who are willing to prescribe.  A recent article in the Journal of Substance Abuse Treatment  polled 558 physicians across the U.S. (with and without a waiver to allow them to prescribe buprenorphine) to find what barriers there were to participating in MAT.  Huhn & Dunn (2017) reported that, of the physicians surveyed,  the main reasons that they failed to increase prescribing were: lack of belief in agonist (e.g., buprenorphine) treatment,  lack of time to treat more patients,  and belief that reimbursement rates would be insufficient. Thirty nine percent of the physicians polled also reported that one thing that would encourage them to prescribe would be to have access to an experienced provider.
The DHHS grant will allow those physicians who do NOT have buprenorphine certification to use telemedicine to link their patients up with certified providers who can prescribe buprenorphine. This may help overcome the barriers to treating those most at risk of being seriously affected by the opioid epidemic.
An August 24, 2018 opinion column in the NY Times (Editorial Board, 2018, August 24) compares states in which opiate use is decreasing to states in which it is not decreasing. States like Hawaii, Massachusetts, North Dakota, Oklahoma, Rhode Island, Utah, Vermont and Wyoming have implemented practices which have resulted in decreased opiate overdose deaths. These states, according to the Centers for Disease Control, have implemented increased access to MAT and to the anti-overdose medication Naloxone. The Times notes that part of the success can be attributed to efforts to increase the number of insured individuals. Massachusetts and Vermont have expanded Medicaid under the Affordable Care Act, and have helped people sign up for private insurance. The percentage of uninsured individuals is lower in Vermont and Massachusetts than the average in the country as a whole. Part of the reason that opiate overdose deaths are not decreasing in states like Maine and Florida is that the uninsured rates are high, and the legislatures have refused to expand Medicaid.

Resources

Azar, Alex (2018, September 19). USA Today Retrieved from https://www.usatoday.com/story/opinion/2018/09/19/donald-trump-opioid-crisis-epidemic-addiction-nalaxone-heroine-column/1347574002/

Editorial Board. (2018, Aug 24). New York Times. On the opioid epidemic. Retrieved from https://www.nytimes.com/2018/08/24/opinion/opioid-epidemic-states.html

Huhn, A. & Dunn, K. (2017). Journal of Substance Abuse Treatment 78, 1–7.